Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • mortality prediction
Early Portopulmonary Hypertension in Cirrhosis: A Prognostic Marker of Increased Mortality
Posted inCardiology Gastroenterology news

Early Portopulmonary Hypertension in Cirrhosis: A Prognostic Marker of Increased Mortality

Posted by MedXY By MedXY 10/27/2025
Early-stage portopulmonary hypertension, defined by revised 2022 ESC/ERS criteria, independently predicts mortality in patients with cirrhosis, underscoring the importance of systematic screening and early intervention.
Read More
Integrating Triglyceride-Glucose Indices with Obesity Measures Enhances Cardiovascular and Mortality Risk Prediction in CKM Syndrome
Posted inCardiology Nephrology news

Integrating Triglyceride-Glucose Indices with Obesity Measures Enhances Cardiovascular and Mortality Risk Prediction in CKM Syndrome

Posted by MedXY By MedXY 10/19/2025
This study demonstrates that triglyceride-glucose-related indices combined with obesity measures significantly predict cardiovascular outcomes and mortality in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3, offering improved prognostic utility.
Read More
Enhanced GRACE 3.0 Score for Personalized Management of Non-ST-Elevation Acute Coronary Syndrome: Insights from a Multinational Validation Study
Posted inCardiology Specialties

Enhanced GRACE 3.0 Score for Personalized Management of Non-ST-Elevation Acute Coronary Syndrome: Insights from a Multinational Validation Study

Posted by MedXY By MedXY 10/19/2025
The updated GRACE 3.0 scoring system improves mortality prediction and personalizes early invasive treatment decisions in non-ST-elevation acute coronary syndrome across ten countries, demonstrating excellent validation and clinical utility.
Read More
NT-proBNP as a Prognostic Biomarker for Mortality in Ischemic Stroke: Insights from a Comprehensive Meta-Analysis
Posted inCardiology news Pathology & Lab Medicine Specialties

NT-proBNP as a Prognostic Biomarker for Mortality in Ischemic Stroke: Insights from a Comprehensive Meta-Analysis

Posted by MedXY By MedXY 08/21/2025
This systematic review and meta-analysis evaluates NT-proBNP's accuracy in predicting mortality among ischemic stroke patients, revealing moderate to high prognostic performance with potential clinical utility in risk stratification.
Read More
Decoding the Link Between Pulmonary Artery Pressures and Mortality in Chronic Heart Failure Patients
Posted inCardiology Clinical Updates news Respiratory Specialties

Decoding the Link Between Pulmonary Artery Pressures and Mortality in Chronic Heart Failure Patients

Posted by MedXY By MedXY 08/17/2025
Remote monitoring of systolic, diastolic, and mean pulmonary artery pressures predicts 2-year all-cause mortality in chronic heart failure across ejection fraction categories, informing personalized management strategies.
Read More
Predicting Long-Term Mortality: Insights from a Multi-Metabolite Signature in the PREDIMED Trial
Posted inDiabetes & Endocrinology news Specialties

Predicting Long-Term Mortality: Insights from a Multi-Metabolite Signature in the PREDIMED Trial

Posted by MedXY By MedXY 08/11/2025
A study identified a robust plasma multi-metabolite signature that predicts long-term all-cause mortality in participants from the PREDIMED trial and several US cohorts, providing new insights into metabolic biomarkers.
Read More
  • Systemic Vulnerability: Why Youths with Prior Out-of-Home Placement Face Longer ED Stays and Higher Restraint Rates
  • Genetic Liability for Suicide Attempt Is Linked to Aggression and Environmental Stressors: New Insights into Polygenic Risk
  • The Landscape of Late-Life Dementia: Why Mixed Neuropathologies Are the Rule, Not the Exception
  • Preparation Is Key: Study Finds Pre-Dose Therapy Hours Predict Success in Psychedelic-Assisted Therapy for Depression
  • Childhood ADHD Traits Linked to Increased Risk of Physical Multimorbidity and Disability in Midlife
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology exercise health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality nutrition obesity older adults oncology Pediatrics Physical Activity precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial SGLT2 inhibitors stroke targeted therapy type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in